Showing posts with label CCB. Show all posts
Showing posts with label CCB. Show all posts

Nifedipine

Nifedipine: A Comprehensive Guide

Nifedipine is a well-established medication, frequently prescribed for heart conditions and high blood pressure. As a key member of the calcium channel blocker family, Nifedipine has consistently proven its worth in cardiovascular medicine. This article offers a holistic and patient-friendly overview of Nifedipine, including its therapeutic uses, dosage, pharmacology, side effects, and updates as of 2025. It aims to bridge the gap between clinical precision and public understanding.

Nifedipine is a dihydropyridine calcium channel blocker that works by inhibiting the influx of calcium ions into vascular smooth muscle and cardiac cells, thereby promoting vasodilation. Since its introduction in the 1970s, Nifedipine has revolutionised the management of angina and hypertension. It is widely respected for its rapid action and overall effectiveness in reducing cardiovascular morbidity. As a medication, it serves as a cornerstone in antihypertensive and anti-anginal therapy.


Image source Google

Verapamil

Verapamil

Verapamil is a well-characterised member of the calcium channel blocker (CCB) family, specifically classified under the phenylalkylamine subclass. It exerts its pharmacological effects primarily on the myocardium and vascular smooth muscle, making it an essential therapeutic agent in cardiovascular medicine. Verapamil’s mechanism of action involves the inhibition of L-type calcium channels, thereby reducing intracellular calcium concentrations. This leads to a reduction in myocardial contractility and vasodilation, culminating in decreased peripheral vascular resistance, lower oxygen demand, and overall improved cardiac efficiency. Its diverse applications in clinical practice underscore its significance in managing various cardiovascular conditions.


Image source Google

Diltiazem

Diltiazem: A Comprehensive Pharmacological Overview

Diltiazem is a non-dihydropyridine calcium channel blocker (CCB) that exerts its pharmacological effects by inhibiting calcium ion influx across myocardial and vascular smooth muscle cells. This action leads to vasodilation, decreased myocardial contractility, and slowed atrioventricular (AV) nodal conduction. Clinically, it is utilised in the management of hypertension, angina pectoris, and various supraventricular arrhythmias. Due to its unique ability to modulate both vascular tone and cardiac conduction, Diltiazem occupies a critical role in cardiovascular therapeutics.


Image source Google

My Blog List